Longitude Capital Partners III, LLC
- SEC CIK
- 0001713663
No open-market purchases or sales filed in the past year.
Current role at each company
- SRRA Sierra Oncology, Inc.10% Owneras of Apr 29, 2022
- INZY Inozyme Pharma, Inc.10% Owneras of Apr 21, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Longitude Capital Partners III, LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
INZY Inozyme Pharma, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2022 (view filing)6:04 PM ET | Apr 19 | 2 days | Enright Patrick G and 3 others10% Owner | PPurchase | +1.35M | $3.69 | +$5.00M | +48.1%4.17M after |
SRRA Sierra Oncology, Inc.
10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2022 (view filing)9:25 PM ET | Feb 2 | Same day | Enright Patrick G and 5 others10% Owner | PPurchase | +175.0K | $27.00 | +$4.72M | New position175.0K after | Duplicate filing |